Story
Loading the article brief, supporting context, and related editorial blocks.
AI BriefWire / Briefing
OpenAI is collaborating with Moderna to accelerate the development of life-saving treatments using AI technology. This partnership aims to enhance drug discovery and improve healthcare outcomes. The integration of AI can significantly reduce the time and cost involved in developing new medicines.
%22%2F%3E%0A%3Ccircle%20cx%3D%22978%22%20cy%3D%22150%22%20r%3D%22210%22%20fill%3D%22rgba(124%2C166%2C199%2C0.16)%22%2F%3E%0A%3Ccircle%20cx%3D%22978%22%20cy%3D%22150%22%20r%3D%22122%22%20fill%3D%22rgba(255%2C255%2C255%2C0.04)%22%20stroke%3D%22rgba(255%2C255%2C255%2C0.12)%22%2F%3E%0A%3Cpath%20d%3D%22M70%20428H1130%22%20stroke%3D%22rgba(208%2C122%2C85%2C0.28)%22%20stroke-width%3D%222%22%20stroke-dasharray%3D%2210%2014%22%2F%3E%0A%3Crect%20x%3D%2276%22%20y%3D%2272%22%20width%3D%22360%22%20height%3D%2242%22%20rx%3D%2221%22%20fill%3D%22rgba(255%2C255%2C255%2C0.06)%22%20stroke%3D%22rgba(255%2C255%2C255%2C0.1)%22%2F%3E%0A%3Ctext%20x%3D%2298%22%20y%3D%2299%22%20fill%3D%22rgba(242%2C244%2C247%2C0.82)%22%20font-family%3D%22Arial%2C%20Helvetica%2C%20sans-serif%22%20font-size%3D%2217%22%20font-weight%3D%22700%22%20letter-spacing%3D%223%22%3EOPENAI%20NEWS%3C%2Ftext%3E%0A%3Ctext%20x%3D%2278%22%20y%3D%22212%22%20fill%3D%22%23F2F4F7%22%20font-family%3D%22Georgia%2C%20'Times%20New%20Roman'%2C%20serif%22%20font-size%3D%2254%22%20font-weight%3D%22700%22%3E%3Ctspan%20x%3D%2278%22%20dy%3D%220%22%3EAccelerating%20the%3C%2Ftspan%3E%3Ctspan%20x%3D%2278%22%20dy%3D%2262%22%3Edevelopment%20of%3C%2Ftspan%3E%3Ctspan%20x%3D%2278%22%20dy%3D%2262%22%3Elife-saving...%3C%2Ftspan%3E%3C%2Ftext%3E%0A%3Crect%20x%3D%2278%22%20y%3D%22502%22%20width%3D%22260%22%20height%3D%2246%22%20rx%3D%2223%22%20fill%3D%22rgba(208%2C122%2C85%2C0.18)%22%20stroke%3D%22rgba(208%2C122%2C85%2C0.32)%22%2F%3E%0A%3Ctext%20x%3D%22104%22%20y%3D%22532%22%20fill%3D%22%23F2F4F7%22%20font-family%3D%22Arial%2C%20Helvetica%2C%20sans-serif%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%3ECore%20AI%3C%2Ftext%3E%0A%3Crect%20x%3D%22900%22%20y%3D%22410%22%20width%3D%22190%22%20height%3D%22190%22%20rx%3D%2238%22%20fill%3D%22rgba(255%2C255%2C255%2C0.06)%22%20stroke%3D%22rgba(255%2C255%2C255%2C0.12)%22%2F%3E%0A%3Ctext%20x%3D%22995%22%20y%3D%22522%22%20text-anchor%3D%22middle%22%20fill%3D%22%23F2F4F7%22%20font-family%3D%22Arial%2C%20Helvetica%2C%20sans-serif%22%20font-size%3D%2292%22%20font-weight%3D%22800%22%3EOP%3C%2Ftext%3E%0A%3C%2Fsvg%3E)
Server-side extracted preview paragraphs from the original source.
Accelerating the development of life-saving treatments.
Moderna and OpenAI partner to accelerate the development of life-saving treatments.
Moderna partners with OpenAI to deploy ChatGPT Enterprise to thousands of employees across the company. Now every function is empowered with AI, creating novel use cases and GPTs that accelerate and expand the impact of every team.
Moderna has been at the intersection of science, technology, and health for more than 10 years. Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines—with the COVID-19 vaccine being their most well-known breakthrough.
The company has partnered with OpenAI since early 2023. Now, ChatGPT Enterprise is evolving how Moderna operates across each function.
Moderna is using its platform for developing mRNA medicines to bring up to 15 new products to market in the next 5 years—from a vaccine against RSV to individualized cancer treatments. In order to achieve its ambitions, Moderna has adopted a people-centric, technology-forward approach, constantly testing new technology and innovation that can increase human capacity and clinical performance.
Moderna adopted generative AI the same way Moderna adopts other technology: with the mindset of using the power of digital to maximize its positive impact on patients. To allow AI to flourish, they knew they needed to start with the user and invest in laying a strong foundation for change.